Background and current knowledge of Chlamydia pneumoniae and atherosclerosis

scientific article

Background and current knowledge of Chlamydia pneumoniae and atherosclerosis is …
instance of (P31):
review articleQ7318358
scholarly articleQ13442814

External links are
P356DOI10.1086/315596
P8608Fatcat IDrelease_p67gfylirzaetf2tj2pwjdn6aq
P698PubMed publication ID10839724
P5875ResearchGate publication ID12478023

P2093author name stringGrayston JT
P2860cites workAtherosclerosis — An Inflammatory DiseaseQ26776972
Secondary prevention trials for coronary artery disease with antibiotic treatment for Chlamydia pneumoniae: design issuesQ33762181
The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniaeQ33843538
Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old)Q34086738
ATYPICAL PNEUMONIA AND PSITTACOSIS.Q35154848
Chlamydial infections of the heartQ35660343
Chlamydia pneumoniae, strain TWAR pneumoniaQ36086894
Unique ultrastructure in the elementary body of Chlamydia sp. strain TWAR.Q36240988
Chlamydia pneumoniae, strain TWAR, as the cause of an outbreak in a boys' school previously called psittacosisQ36473368
Lack of association between first myocardial infarction and past use of erythromycin, tetracycline, or doxycyclineQ37093492
Value of animal models for Chlamydia pneumoniae-related atherosclerosisQ37877532
Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosisQ37877720
Azithromycin in control of trachomaQ37877870
Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient miceQ37878302
Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS StudyQ37878753
Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with ChlamydQ37878769
Chlamydia infections and heart disease linked through antigenic mimicryQ37878963
Antibiotics and risk of subsequent first-time acute myocardial infarctionQ37879181
Poor correlation between microimmunofluorescence serology and polymerase chain reaction for detection of vascular Chlamydia pneumoniae infection in coronary artery disease patients.Q37879706
Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expressionQ37880399
Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouseQ37881023
Induction of macrophage foam cell formation by Chlamydia pneumoniaeQ37881436
Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit modelQ37881464
Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosisQ37881850
Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future researchQ37881887
Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarctionQ37882420
Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimenQ37882581
Prevalence of positive serology for acute Chlamydia pneumoniae infection in emergency department patients with persistent coughQ37883379
Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniaeQ37884222
Reactivation of Chlamydia pneumoniae lung infection in mice by cortisoneQ37886683
An epidemic of infections due to Chlamydia pneumoniae in military conscriptsQ37890430
Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteriesQ37891287
Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979Q37892533
Chlamydia pneumoniae infections in Norway 1981-87 earlier diagnosed as ornithosisQ37895606
Culture-negative endocarditis probably due to Chlamydia pneumoniaeQ37897113
Countrywide epidemics of Chlamydia pneumoniae, strain TWAR, in Scandinavia, 1981-1983.Q37898201
Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarctionQ37899465
Epidemics of pneumonia caused by TWAR, a new Chlamydia organism, in military trainees in FinlandQ37900395
Distal tubal obstruction induced by repeated Chlamydia trachomatis salpingeal infections in pig-tailed macaquesQ37901508
A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infectionsQ37902805
An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaciQ37904432
Myocarditis as a complication of infantile Chlamydia trachomatis pneumonitisQ37906752
Pericardial and Myocardial Disease Associated with Serological Evidence of Infection by Agents of the Psittacosis-Lymphogranuloma Venereum Group (Chlamydiaceae)Q37915028
Deoxyribonucleic Acid Relatedness of Chlamydia sp. Strain TWAR to Chlamydia trachomatis and Chlamydia psittaciQ45311678
Chlamydia pneumoniae sp. nov. for Chlamydia sp. Strain TWARQ45311740
Infections and atherosclerosis: new clues from an old hypothesis?Q53565811
P407language of work or nameEnglishQ1860
P921main subjectatherosclerosisQ12252367
Chlamydia pneumoniaeQ62869737
P304page(s)S402-10
P577publication date2000-06-01
P1433published inJournal of Infectious DiseasesQ4051141
P1476titleBackground and current knowledge of Chlamydia pneumoniae and atherosclerosis
P478volume181 Suppl 3